The Government will expand eligibility of the Continuous Glucose Monitoring (CGM) program to include people under 21 years of age with congenital hyperinsulinaemia. Free access to CGM monitoring devices will help this high need group to better manage this difficult disease and further support their families and carers.
Improving Access to Medicines – expansion of the Continuous Glucose Monitoring program
About this resource
Publication date:
Publication type:
Fact sheet
Audience:
General public
Language:
English
Part of a collection: